Your browser doesn't support javascript.
loading
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.
Provencio, Mariano; Rodríguez-Abreu, Delvys; Ortega, Ana L; Serrano, Gloria; Aguado, Carlos; Franco, Fernando; Gutierrez, Vanesa; López Vivanco, Guillermo; Guirado, María; Benítez, Gretel; Estival, Anna; Calvo, Virginia; Jiménez, Beatriz; Arasanz, Hugo; Coves, Juan; Majem, Margarita; Massutí, Bartomeu; Vázquez, Sergio; Juan-Vidal, Oscar; Collazo-Lorduy, Ana; Gozálvez, Clara L; Del Barco, Edel; Rosero, Adriana; Bosch-Barrerra, Joaquim; Moreno, María A; Mielgo-Rubio, Xabier; Villa, José C; López-Martin, Ana; Córdoba, Juan F; de Asís Aparisi, Francisco; Zafra, Marta; Mosquera, Joaquín; Pérez Altozano, Javier; Nadal, Ernest; Catot, Silvia; Balsalobre, José; de Portugal, Teresa; Martín, Paloma; Cuesta de Juan, Susanaa; Cobo, Manuel.
Afiliação
  • Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Rodríguez-Abreu D; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain.
  • Ortega AL; Medical Oncology Department, Hospital Universitario de Jaén, Jaén, Spain.
  • Serrano G; Medical Oncology Department, Hospital Universiario Infanta Leonor, Madrid, Spain.
  • Aguado C; Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.
  • Franco F; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Gutierrez V; Medical Oncology Department, Hospital Universitario Regional de Málaga, Málaga, Spain.
  • López Vivanco G; Medical Oncology Department, Hospital Universitario Cruces, Barakaldo, Spain.
  • Guirado M; Medical Oncology Department, Hospital General Universitario de Elche, Alicante, Spain.
  • Benítez G; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain.
  • Estival A; Catalan Institute of Oncology, Hospital Universitari Germans Trias i Pujol, B-ARGO, IGTP, Badalona, Spain.
  • Calvo V; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Jiménez B; Medical Oncology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Arasanz H; Medical Oncology Department, Complejo Hospitalario Navarra-Navarrabiomeed, Pamplona, Spain.
  • Coves J; Medical Oncology Department, Hospital Universitari Son LLàtzer, Palma de Mallorca, Spain.
  • Majem M; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Massutí B; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain.
  • Vázquez S; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Juan-Vidal O; Medical Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Collazo-Lorduy A; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Gozálvez CL; Medical Oncology Department, Hospital Universitari Sant Joan de Reus, Reus, Spain.
  • Del Barco E; Medical Oncology Department, Hospital Clínico Universitario de Salamanca, Salamanca, Spain.
  • Rosero A; Medical Oncology Department, Hospital Universitario Infanta Cristina, Madrid, Spain.
  • Bosch-Barrerra J; Medical Oncology Department, Institut Català d'Oncologia, Girona, Spain.
  • Moreno MA; Medical Oncology Department, Hospital Universitario de Puerto Real, Cádiz, Spain.
  • Mielgo-Rubio X; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Villa JC; Medical Oncology Department, Hospital General Universitario Ciudad Real, Ciudad Real, Spain.
  • López-Martin A; Medical Oncology Department, Hospital Universitario Severo Ochoa, Madrid, Spain.
  • Córdoba JF; Medical Oncology Department, Hospital Universitario Arnau de Vilanova, Lleida, Spain.
  • de Asís Aparisi F; Medical Oncology Department, Hospital General Universitario de Valencia, Valencia, Spain.
  • Zafra M; Medical Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain.
  • Mosquera J; Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
  • Pérez Altozano J; Medical Oncology Department, Hospital Virgen de los Lirios, Alicante, Spain.
  • Nadal E; Medical Oncology Department, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain.
  • Catot S; Medical Oncology Department, Altaia, Xarxa Assistencial Universitaria Manresa, Barcelona, Spain.
  • Balsalobre J; Medical Oncology Department, Hospital General Universitario Santa Lucia, Cartagena, Murcia, Spain.
  • de Portugal T; Medical Oncology Department, Complejo Hospitalario de Zamora, Zamora, Spain.
  • Martín P; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Cuesta de Juan S; Laboratorio Central, Eurofins Megalab, Madrid, Spain.
  • Cobo M; Medical Oncology Department, Hospital Universitario Regional de Málaga, Málaga, Spain.
Transl Lung Cancer Res ; 11(1): 53-63, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35242627
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha